Suppr超能文献

肾上腺脑白质营养不良:原发性艾迪生病患儿中被遗忘的诊断。

Adrenoleukodystrophy: a forgotten diagnosis in children with primary Addison's disease.

作者信息

Nascimento Marta, Rodrigues Nádia, Espada Filipa, Fonseca Marcelo

机构信息

Department of Pediatrics, Hospital Pedro Hispano, Matosinhos, Portugal.

出版信息

BMJ Case Rep. 2012 Aug 21;2012:bcr2012006308. doi: 10.1136/bcr-2012-006308.

Abstract

The X linked adrenoleukodystrophy (X-ALD) is a peroxisomal disease caused by defects of the ABCD1 gene on chromosome Xq28 leading to accumulation of very long chain fatty acids (VLCFA), progressive demyelination and adrenal insufficiency. An 8-year-old boy was referred to our paediatric endocrinology clinic due to fatigue and hyperpigmentation with onset at 2-years old. Blood tests revealed mineralocorticoid insufficiency. Serum adrenocorticotropic hormone and cortisol concentrations were compatible with adrenal insufficiency. Adrenal antibodies were negative. The elevated plasmatic concentration of VLCFA and the genotype analysis with sequencing of ABCD1 gene established the diagnosis of X-ALD. Brain MRI showed demyelination of white matter in the peritrigonal regions. Steroid replacement was started with good response. He initiated restriction of VLCFA by reducing the intake of fatty foods. The authors highlight the importance of suspecting of X-ALD in the aetiology of primary adrenal insufficiency as the first sign of the disease.

摘要

X连锁肾上腺脑白质营养不良(X-ALD)是一种过氧化物酶体疾病,由位于Xq28染色体上的ABCD1基因缺陷引起,导致极长链脂肪酸(VLCFA)蓄积、进行性脱髓鞘和肾上腺功能不全。一名8岁男孩因2岁起病出现疲劳和色素沉着而被转诊至我们的儿科内分泌门诊。血液检查显示盐皮质激素不足。血清促肾上腺皮质激素和皮质醇浓度与肾上腺功能不全相符。肾上腺抗体为阴性。VLCFA血浆浓度升高以及对ABCD1基因进行测序的基因型分析确诊为X-ALD。脑部磁共振成像显示三角区周围白质脱髓鞘。开始进行类固醇替代治疗,反应良好。他通过减少脂肪食物的摄入开始限制VLCFA。作者强调,在原发性肾上腺功能不全的病因中怀疑X-ALD作为该病的首发症状的重要性。

相似文献

1
Adrenoleukodystrophy: a forgotten diagnosis in children with primary Addison's disease.
BMJ Case Rep. 2012 Aug 21;2012:bcr2012006308. doi: 10.1136/bcr-2012-006308.
2
A 29-year-old patient with adrenoleukodystrophy presenting with Addison's disease.
Endocr J. 2020 Jun 29;67(6):655-658. doi: 10.1507/endocrj.EJ19-0576. Epub 2020 Feb 26.
3
X-linked adrenoleukodystrophy and primary adrenal insufficiency.
Front Endocrinol (Lausanne). 2023 Nov 16;14:1309053. doi: 10.3389/fendo.2023.1309053. eCollection 2023.
4
[Primary adrenal insufficiency as the form of onset of adrenoleukodystrophy in a 4-year-old boy].
Endocrinol Nutr. 2009 Jan;56(1):40-2. doi: 10.1016/S1575-0922(09)70192-5. Epub 2009 Mar 1.
5
Easily misdiagnosed X-linked adrenoleukodystrophy.
Ital J Pediatr. 2024 Jul 2;50(1):124. doi: 10.1186/s13052-024-01669-y.
6
Novel Gene Mutation in a Korean Patient with X-Linked Adrenoleukodystrophy Presenting with Addison's Disease.
Endocrinol Metab (Seoul). 2020 Mar;35(1):188-191. doi: 10.3803/EnM.2020.35.1.188.
7
X-linked adrenoleukodystrophy is a frequent cause of idiopathic Addison's disease in young adult male patients.
J Clin Endocrinol Metab. 1996 Feb;81(2):470-4. doi: 10.1210/jcem.81.2.8636252.
8
The clinical spectrum of X-linked adrenoleukodystrophy: from Addison's-only in men to middle-age neurologic manifestations in women.
Hormones (Athens). 2022 Mar;21(1):33-40. doi: 10.1007/s42000-021-00325-y. Epub 2021 Oct 15.
9
[X-linked adrenoleukodystrophy].
Ann Endocrinol (Paris). 2007 Dec;68(6):403-11. doi: 10.1016/j.ando.2007.04.002. Epub 2007 May 29.
10
Adult cerebral adrenoleukodystrophy and Addison's disease in a female carrier.
Gene. 2014 Jul 10;544(2):248-51. doi: 10.1016/j.gene.2014.04.056. Epub 2014 Apr 25.

引用本文的文献

1
Cerebral adrenoleukodystrophy presenting as status epilepticus: Unveiling the neurological maze.
Radiol Case Rep. 2024 Oct 30;20(1):414-418. doi: 10.1016/j.radcr.2024.10.018. eCollection 2025 Jan.
2
A patient with X-linked adrenoleukodystrophy presenting with central precocious puberty: a case report.
Endocrine. 2024 Feb;83(2):353-356. doi: 10.1007/s12020-023-03562-w. Epub 2023 Oct 16.
3
Early Detection of Adrenal Insufficiency: The Impact of Newborn Screening for Adrenoleukodystrophy.
J Clin Endocrinol Metab. 2023 Oct 18;108(11):e1306-e1315. doi: 10.1210/clinem/dgad286.
4
Adrenoleukodystrophy in the Differential Diagnosis of Boys Presenting with Primary Adrenal Insufficiency without Adrenal Antibodies.
J Clin Res Pediatr Endocrinol. 2021 Jun 2;13(2):212-217. doi: 10.4274/jcrpe.galenos.2020.2020.0214. Epub 2020 May 12.
5
A Rare Case of Autoimmune Polyglandular Syndrome Type 2 in a Child With Persistent Fatigue.
Glob Pediatr Health. 2019 May 1;6:2333794X19845074. doi: 10.1177/2333794X19845074. eCollection 2019.
6
Clinical, biochemical, neuroimaging and molecular findings of X-linked Adrenoleukodystrophy patients in South China.
Metab Brain Dis. 2015 Dec;30(6):1439-44. doi: 10.1007/s11011-015-9717-6. Epub 2015 Aug 12.

本文引用的文献

1
Adrenoleukodystrophy.
Endocr Dev. 2011;20:149-160. doi: 10.1159/000321236. Epub 2010 Dec 16.
2
Current and future pharmacological treatment strategies in X-linked adrenoleukodystrophy.
Brain Pathol. 2010 Jul;20(4):845-56. doi: 10.1111/j.1750-3639.2010.00393.x.
3
Pathomechanisms underlying X-adrenoleukodystrophy: a three-hit hypothesis.
Brain Pathol. 2010 Jul;20(4):838-44. doi: 10.1111/j.1750-3639.2010.00392.x.
4
Lovastatin in X-linked adrenoleukodystrophy.
N Engl J Med. 2010 Jan 21;362(3):276-7. doi: 10.1056/NEJMc0907735.
5
Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy.
Science. 2009 Nov 6;326(5954):818-23. doi: 10.1126/science.1171242.
6
The human peroxisomal ABC half transporter ALDP functions as a homodimer and accepts acyl-CoA esters.
FASEB J. 2008 Dec;22(12):4201-8. doi: 10.1096/fj.08-110866. Epub 2008 Aug 29.
8
"Lorenzo's oil" therapy for X-linked adrenoleukodystrophy: rationale and current assessment of efficacy.
J Mol Neurosci. 2007 Sep;33(1):105-13. doi: 10.1007/s12031-007-0041-4.
9
[X-linked adrenoleukodystrophy].
Ann Endocrinol (Paris). 2007 Dec;68(6):403-11. doi: 10.1016/j.ando.2007.04.002. Epub 2007 May 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验